Evaluation of the tubular effects of dapagliflozin using 1HNMR spectroscopy.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2016
At a glance
- Drugs Chlortalidone (Primary) ; Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 25 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 25 Jan 2016 New trial record